Loading...
Lenvatinib — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Lenvatinib
2025-Q4
Comprehensive analysis of India’s lenvatinib export trade — suppliers, buyers, prices, routes, and every shipment record.
116
Shipments
$112K
Trade Value
48
Suppliers
31
Buyers
29
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/lenvatinib
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s lenvatinib trade — 2025-Q4
KEY TAKEAWAY
Lenvatinib 2025-Q4 exports total $112.5K across 29 countries, with GENERAL DRUG PVT LTD commanding 24.7% market share.
TOTAL SHIPMENTS
116
2025-Q4
EXPORT VALUE
$112.5K
FOB USD
TOTAL QUANTITY
38.4K
units shipped
INDIAN SUPPLIERS
48
unique exporters
GLOBAL BUYERS
31
unique importers
DESTINATIONS
29
countries
MEDIAN UNIT PRICE
$12.36
per unit
TOP-5 SHARE
60.9%
of total USD
BRANDED SHARE
65.5%
76 shipments
DOSAGE FORMS
2
product types
6 KEY FINDINGS
1
GENERAL DRUG PVT LTD is India's #1 Lenvatinib exporter with $27.8K (24.7% market share).→ §5, Indian Supplier Rankings
2
Lenvatinib reached 29 countries, with Afghanistan as the top destination ($33.6K).→ §4, Global Destination Map
3
Market concentration is low (HHI: 1083) — top 10 suppliers control 76.6% of exports.→ §5, Indian Supplier Rankings
4
93.5% of buyers (29 of 31) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Capsule dominates (60.7%) across 2 dosage forms.→ §7, Price Benchmarks
6
29 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 GENERAL DRUG PVT LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian lenvatinib exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Lenvatinib report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial lenvatinib trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian lenvatinib suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Lenvatinib India trade report
Product scope
Lenvatinib
All variants merged — branded and generic formulations of lenvatinib
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
116
Every commercial lenvatinib trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $9.6K, Nov $64.9K, Dec $38.0K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$9.6K
Oct USD
12 shipments
2
$64.9K
Nov USD
+577.4% MoM
3
$38.0K
Dec USD
-41.4% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 577.4% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $10K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $112K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $55K rise in Nov, $27K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $10K | 12 shipments |
| Nov | $65K | 28 shipments |
| Dec | $38K | 76 shipments |
| Q4 Total | $112K | 116 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Afghanistan held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MALLESHWAR SPECIALITIES maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import lenvatinib from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Afghanistan absorbs 29.9% of India’s 2025-Q4 lenvatinib trade ($33.6K). Beyond the top 10 destinations, 29 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 11 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 29 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much lenvatinib India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$86K
76.3% of trade
11 countries · 60 shipments
Europe
$2K
1.5% of trade
2 countries · 4 shipments
Americas
$11K
9.5% of trade
6 countries · 23 shipments
Africa
$14K
12.8% of trade
10 countries · 29 shipments
Fig 4.1 Afghanistan is the #1 corridor ($34K) — 29 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian lenvatinib it receives (light = low, dark = high). Orange arcs radiate from India to the top 29 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Afghanistan | $34K | 9 | SALUS PHARMACEUTICALS | $18K | RESCUERS LIFE SCIENCES LTD | $8K | KWALITY PHARMACEUTICALS LTD | $7K |
| 2 | United Arab Emirates | $28K | 2 | GENERAL DRUG PVT LTD | $28K | SEATRACK INTERNATIONAL TRADEX PVT LTD | $606 | — | — |
| 3 | Philippines | $11K | 12 | MALLESHWAR SPECIALITIES | $7K | PHARMA CHOICE LLP | $4K | EXQUISITE PHARMA LLP | $0 |
| 4 | Mexico | $5K | 8 | MYGENIC HEALTHCARE PVT LTD | $5K | VAMA HEALTH WORLD LLP | $727 | MEDINEX HEALTHCARE | $132 |
| 5 | Cameroon | $4K | 6 | NEOPHAR PHARMACEUTICALS PVT LTD | $3K | RUN MEDWAY | $612 | MELON GLOBALCARE | $50 |
| 6 | Uganda | $3K | 4 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | $3K | — | — | — | — |
| 7 | Laos | $3K | 10 | KASO PHARMACEUTICALS | $2K | LEOWIN HEALTHCARE LLP | $734 | ASPIDA LIFE SCIENCES PVT LTD | $383 |
| 8 | Burkina Faso | $3K | 4 | SANSKRUTI PHARMA | $3K | — | — | — | — |
| 9 | Maldives | $3K | 8 | NU HOSPITALS PVT LTD | $2K | HEMS ( INDIA ) | $533 | MC PHARMA DISTRIBUTORS | $406 |
| 10 | Iraq | $2K | 4 | VATS INDUSTRIES PVT LTD | $2K | AKSHAR PHARMA | $264 | HEET HEALTHCARE PVT LTD | $153 |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 76.3% of USD — but Afghanistan is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
29.9%
#1 country share
Afghanistan alone
73.2%
Top 5 share
5 of 29 countries
92.9%
Top 15 share
Long tail of 14 countries = 7.1%
HHI 1709
Destination HHI
Moderately concentrated
29
Countries served
Global pharma reach from India
11
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
48 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
GENERAL DRUG PVT LTD ($27.8K, 24.7% share) and SALUS PHARMACEUTICALS ($18.2K) together control 40.9% of India’s 2025-Q4 lenvatinib trade. The top 5 suppliers hold 60.9%. 48 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian lenvatinib suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 GENERAL DRUG PVT LTD leads by $10K over SALUS PHARMACEUTICALS — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: GENERAL DRUG PVT is #1 by value but #15 by volume.
Fig 5.2 MALLESHWAR SPECIALITIES also leads by shipment count (6) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: GENERAL DRUG PVT moves from #15 by volume to #1 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 48 lenvatinib suppliers split into strategic segments
KEY TAKEAWAY
12 suppliers (25%) generate 80.1% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 GENERAL DRUG PVT LTD and SALUS PHARMACEUTICALS sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 80.1% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | NEOPHAR PHARMACEUTICALS PVT LTD | 2 | 1 | $3K |
| 2 | GENERAL DRUG PVT LTD | 1 | 1 | $28K |
| 3 | SALUS PHARMACEUTICALS | 1 | 1 | $18K |
| 4 | RESCUERS LIFE SCIENCES LTD | 1 | 1 | $8K |
| 5 | MALLESHWAR SPECIALITIES | 1 | 1 | $7K |
| 6 | KWALITY PHARMACEUTICALS LTD | 1 | 1 | $7K |
| 7 | MYGENIC HEALTHCARE PVT LTD | 1 | 1 | $5K |
| 8 | PHARMA CHOICE LLP | 1 | 1 | $4K |
| 9 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | 1 | 1 | $3K |
| 10 | SANSKRUTI PHARMA | 1 | 2 | $3K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the lenvatinib manufacturing hubs
KEY TAKEAWAY
Mumbai and Baddi together account for $54K of India’s 2025-Q4 lenvatinib trade.
Fig 5.5 Mumbai (12 exporters, $36K) and Baddi (1 exporters, $18K) are India’s lenvatinib capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
60.9%
Top 5 share
5 of 48 suppliers
76.6%
Top 10 share
10 of 48 suppliers
80.1%
Top 25% share
12 suppliers = 80% USD
HHI 1083
Supplier HHI
Competitive
48
Total suppliers
shipped Lenvatinib in 2025-Q4
20+ cities
Indian hubs
Mumbai and Baddi lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | SANSKRUTI PHARMA | $3K |
#10
2025-Q4 USD
$3K
2.6% market share
SHIPMENTS
6
avg $490/ship
COUNTRIES
2
destination markets
BUYERS
2
unique importers
BRANDED
83%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Burkina Faso is the #1 market at $3K (95% of trade), followed by Brazil at $144. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Burkina Faso | $3K | 4 | 95.1% |
| 2 | Brazil | $144 | 2 | 4.9% |
MONTHLY TREND
Nov peaked at $3K. Oct was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Burkina Faso | $2K | N/A |
| Undisclosed buyer | Burkina Faso | $737 | N/A |
#10
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
SANSKRUTI PHARMA — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 Burkina Faso absorbs $3K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
31 importers across 29 countries — who is buying Indian lenvatinib and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 56.2% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian lenvatinib. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 BEHZAD EMRAN LTD is the #1 importer at $18K (16.2%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
94%
Single-source
29 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
6%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source lenvatinib from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Afghanistan 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BEHZAD EMRAN LTD | SALUS PHARMACEUTICALS | $18K | $1.819 | Capsule |
| ETEMED MOSLEH LTD | RESCUERS LIFE SCIENC… | $8K | $2.944 | Capsule |
| TRUST ANESTHETIC LTD | KWALITY PHARMACEUTIC… | $7K | $0.480 | Capsule |
| SARTAJ ENTERPRISES LTD | SARTAJ PHARMA PVT LTD | $261.155 | $0.068 | Capsule |
Philippines 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| RENATO C LOZADA | MALLESHWAR SPECIALIT… | $7K | $49.203 | Capsule |
| IMPORT INNOVATORS VENT… | PHARMA CHOICE LLP | $4K | $12.665 | Tablet |
Maldives 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| INDIRA GANDHI MEMOROAL… | NU HOSPITALS PVT LTD | $2K | $3.398 | Capsule |
| STATE TRADING ORGANIZA… | MC PHARMA DISTRIBUTORS | $406.206 | $0.829 | Capsule |
Jamaica 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| DRJOHN NEWMAN | SHREE KRISHNA LIFECARE | $2K | $182.908 | Capsule |
| TISHEENA ROACH (BSO) | JEEDNYA PHARMA | $2.697 | $0.030 | Capsule |
Iraq 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ATLAS TRADING COMPANY | VATS INDUSTRIES PVT … | $2K | $31.036 | Capsule |
| ZHARAWA LTD | RELICURE HEALTHCARE | $2.439 | $0.488 | Capsule |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | BEHZAD EMRAN LTD | Afghanistan | $18K | $18K | Mid |
| 2 | ETEMED MOSLEH LTD | Afghanistan | $8K | $2K | Budget |
| 3 | RENATO C LOZADA | Philippines | $7K | $1K | Budget |
| 4 | TRUST ANESTHETIC LTD | Afghanistan | $7K | $7K | Budget |
| 5 | IMPORT INNOVATORS VE… | Philippines | $4K | $2K | Budget |
| 6 | ONLT | Uganda | $3K | $808.000 | Budget |
| 7 | NANG DAO | Laos | $2K | $1K | Budget |
| 8 | INDIRA GANDHI MEMORO… | Maldives | $2K | $917.000 | Budget |
| 9 | DRJOHN NEWMAN | Jamaica | $2K | $823.000 | Budget |
| 10 | ATLAS TRADING COMPANY | Iraq | $2K | $2K | Budget |
| 11 | ATLANT ATTIBIA PHARM… | Libya | $1K | $712.000 | Budget |
| 12 | TO THE, IMPORTING DE… | Switzerland | $1K | $1K | Budget |
| 13 | SHINE KHANT CO LTD | Myanmar | $1K | $1K | Budget |
| 14 | MINISTRY OF HEALTH (… | Seychelles | $791.425 | $791.000 | Budget |
| 15 | AS PER INVOICE MEXICO | Mexico | $727.108 | $727.000 | Budget |
| 16 | CLYZ PHARMA SARL | Cameroon | $611.960 | $612.000 | Budget |
| 17 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | $605.610 | $606.000 | Budget |
| 18 | VANTERPOOL ENTERPRIS… | British Virgin Islands | $590.799 | $295.000 | Budget |
| 19 | STATE TRADING ORGANI… | Maldives | $406.206 | $81.000 | Budget |
| 20 | THE PURCHASE DEPARTM… | Chile | $336.093 | $336.000 | Budget |
| 21 | LINDEE ENTERPRISES P… | Singapore | $273.199 | $273.000 | Budget |
| 22 | SARTAJ ENTERPRISES LTD | Afghanistan | $261.155 | $131.000 | Budget |
| 23 | FARMACIA ETICA SPA | Chile | $53.597 | $27.000 | Budget |
| 24 | ROYAL PHARMA COMPANY | Egypt | $47.690 | $24.000 | Budget |
| 25 | NAME : AYGUN | Azerbaijan | $8.326 | $2.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 GENERAL DRUG PVT LTD → BEHZAD EMRAN LTD is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian lenvatinib prices vary by supplier, country and dosage form
KEY TAKEAWAY
Lenvatinib prices span 5193× ($0.040 → $206.02). The coefficient of variation is 1.43. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.040 | Lowest observed unit price |
| P5 | $0.082 | 5th percentile |
| P25 | $0.852 | 25th percentile (Q1) |
| Median | $12.36 | 50th percentile (Q2) |
| P75 | $31.23 | 75th percentile (Q3) |
| P95 | $61.41 | 95th percentile |
| Max | $206.02 | Highest observed unit price |
| Mean | $22.61 | Arithmetic average |
| CV | 143% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 SHREE KRISHNA LIFECARE prices at $171.35/unit vs market median $12.36.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. RESCUERS LIFE SCIENCES Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. MALLESHWAR SPECIALITIES Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. SALUS PHARMACEUTICALS Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. VATS INDUSTRIES PVT Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | GENERAL DRUG PVT… | United Arab Emirates | Tablet | 42 | $28K | $660.83 | Specialty / small-batch |
| Dec 2025 | SHREE KRISHNA LI… | Jamaica | Capsule | 6 | $1K | $206.02 | Specialty / small-batch |
| Dec 2025 | SPECIALITY MEDIC… | Brazil | Capsule | 4 | $682.83 | $170.71 | Specialty / small-batch |
| Dec 2025 | SHREE KRISHNA LI… | Jamaica | Capsule | 3 | $410.02 | $136.67 | Specialty / small-batch |
| Oct 2025 | SPR ONCOCARE PVT… | Libya | Tablet | 10 | $977.57 | $97.76 | Specialty / small-batch |
| Dec 2025 | SARA TRADING CORP | British Virgin Islands | Capsule | 4 | $279.52 | $69.88 | Specialty / small-batch |
| Dec 2025 | SPECIALITY MEDIC… | Brazil | Capsule | 6 | $397.73 | $66.29 | Specialty / small-batch |
| Dec 2025 | K. K. PHARMA SOL… | Libya | Capsule | 8 | $418.90 | $52.36 | Specialty / small-batch |
| Dec 2025 | SARA TRADING CORP | British Virgin Islands | Tablet | 6 | $311.28 | $51.88 | Specialty / small-batch |
| Oct 2025 | MALLESHWAR SPECI… | Philippines | Capsule | 10 | $492.03 | $49.20 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | JEEDNYA PHARMA | Jamaica | Capsule | 90 | $2.70 | $0.030 | Small sample / trial shipment |
| Dec 2025 | VINAYAK DRUGS AN… | Nigeria | Tablet | 200 | $7.93 | $0.040 | Small sample / trial shipment |
| Dec 2025 | ONCOHEAL HEALTHC… | Laos | Tablet | 19 | $0.805 | $0.042 | Small sample / trial shipment |
| Dec 2025 | SARTAJ PHARMA PV… | Afghanistan | Capsule | 2K | $101.59 | $0.046 | |
| Dec 2025 | ONCOHEAL HEALTHC… | Laos | Tablet | 50 | $3.62 | $0.072 | Small sample / trial shipment |
| Dec 2025 | M T MADON EXPORTS | Somalia | Capsule | 30 | $2.36 | $0.079 | Small sample / trial shipment |
| Dec 2025 | AL-ROYAL PHARMAC… | Egypt | Capsule | 300 | $24.01 | $0.080 | Small sample / trial shipment |
| Dec 2025 | ONCOHEAL HEALTHC… | Laos | Tablet | 30 | $2.56 | $0.085 | Small sample / trial shipment |
| Dec 2025 | SARTAJ PHARMA PV… | Afghanistan | Capsule | 2K | $159.56 | $0.098 | |
| Dec 2025 | VINAYAK DRUGS AN… | Nigeria | Tablet | 4 | $0.403 | $0.101 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship lenvatinib, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Lenvatinib leaves India through 6+ ports. The top 5 (DELHI AIR, AHMEDABAD AIR, MUMBAI AIR (SAHAR)) handle 99.8% of total USD. AIR moves 98% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 DELHI AIR handles $44K — top 6 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 KABUL is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 98% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$112K
99.8% of USD · 98.3% of ships
ICD
$160
0.1% of USD · 0.9% of ships
SEA
$18
0.0% of USD · 0.9% of ships
Fig 8.3 The dominant corridor is DELHI AIR → Air → Asia ($38K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Burkina Faso is the most concentrated destination (HHI 10000, 1 suppliers). Afghanistan is the most competitive (HHI 3958).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Burkina Faso (HHI 10,000) is the most concentrated — Afghanistan (HHI 3,958) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| BEHZAD EMRAN LTD | Afghanistan | SALUS PHARMACEUT… | $18K | 1 | MEDIUM |
| ETEMED MOSLEH LTD | Afghanistan | RESCUERS LIFE SC… | $8K | 5 | MEDIUM |
| RENATO C LOZADA | Philippines | MALLESHWAR SPECI… | $7K | 6 | MEDIUM |
| TRUST ANESTHETIC LTD | Afghanistan | KWALITY PHARMACE… | $7K | 1 | MEDIUM |
| IMPORT INNOVATORS VE… | Philippines | PHARMA CHOICE LLP | $4K | 2 | MEDIUM |
| ONLT | Uganda | BDR PHARMACEUTIC… | $3K | 4 | MEDIUM |
| NANG DAO | Laos | KASO PHARMACEUTI… | $2K | 2 | MEDIUM |
| INDIRA GANDHI MEMORO… | Maldives | NU HOSPITALS PVT… | $2K | 2 | MEDIUM |
Conclusion: 29 buyers depend on exactly one Indian supplier, representing $63K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Afghanistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Philippines | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mexico | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Cameroon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Uganda | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Laos | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Burkina Faso | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Maldives | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Iraq | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Libya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Jamaica | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Singapore | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lebanon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Afghanistan | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Burkina Faso lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Afghanistan (4 suppliers) | This Q | HIGH |
| A6 | Enter United Arab Emirates (2 suppliers) | This Q | MED |
| A8 | Build United Arab Emirates distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Afghanistan tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Afghanistan | Asia | 4 | $34K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 2 | United Arab Emirates | Other | 2 | $28K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Philippines | Asia | 3 | $11K | -48.5% | LOW | Low competition (3 suppliers), accessible market |
| 4 | Mexico | Other | 3 | $5K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 5 | Cameroon | Africa | 3 | $4K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 6 | Uganda | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Laos | Asia | 4 | $3K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 8 | Burkina Faso | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Maldives | Asia | 3 | $3K | -100% | LOW | Low competition (3 suppliers), accessible market |
| 10 | Iraq | Other | 4 | $2K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 11 | Libya | Africa | 2 | $2K | -70.6% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Kenya | Africa | 2 | $2K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Jamaica | Other | 2 | $2K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Singapore | Asia | 4 | $1K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 15 | Lebanon | Other | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 116 2025-Q4 Lenvatinib shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/lenvatinib
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 116 2025-Q4 lenvatinib shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian lenvatinib shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
116
across all regions
TOTAL USD
$112K
2025-Q4 FOB value
UNITS
38.4K
tablets, capsules, etc.
SUPPLIERS
48
Indian exporters
BUYERS
31
global importers
COUNTRIES
29
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $14K (12.8%), spanning 10 countries.
48 Indian suppliers shipped to 31 buyers across 29 countries — average shipment value $969.60.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
10 countries · 29 shipments · $14K · 14 Indian suppliers · 8 buyers
SHIPMENTS
29
USD
$14K
COUNTRIES
10
SUPPLIERS
14
BUYERS
8
HHI
1,681
moderate
Top 10 destination countries in Africa
1
Cameroon (27.1%)
$4K
2
Uganda (22.5%)
$3K
3
Burkina Faso (19.5%)
$3K
4
Libya (12.8%)
$2K
5
Kenya (12.1%)
$2K
6
Seychelles (5.5%)
$791.42
7
Egypt (0.3%)
$47.69
8
Nigeria (0.1%)
$9.34
9
Somalia (0.1%)
$7.91
10
DR Congo (0.0%)
$1.72
Top 14 Indian suppliers into Africa
1
BDR PHARMACEUTICALS INTERNATIONAL PVT LTD
$3K
2
NEOPHAR PHARMACEUTICALS PVT LTD
$3K
3
SANSKRUTI PHARMA
$3K
4
R.S. SURGIPHARM PVT LTD
$2K
5
SPR ONCOCARE PVT LTD
$1K
6
SAYAR LIFE-CARE
$791.42
7
RUN MEDWAY
$611.96
8
K. K. PHARMA SOLUTIONS
$418.90
9
RMPL PHARMA LLP
$84.58
10
MELON GLOBALCARE
$50.02
11
AL-ROYAL PHARMACEUTICAL PVT LTD
$47.69
12
VINAYAK DRUGS AND SURGICALS
$9.34
13
M T MADON EXPORTS
$7.91
14
YOGI CARE PHARMACEUTICAL PVT LTD
$1.72
Top 6 Africa importers
1
ONLT · Uganda
$3K
2
ATLANT ATTIBIA PHARMACEUTICALS · Libya
$1K
3
MINISTRY OF HEALTH ( CLAUDE JULIEN · Seychelles
$791.42
4
CLYZ PHARMA SARL · Cameroon
$611.96
5
ROYAL PHARMA COMPANY · Egypt
$47.69
6
MOHAMED AHEMED MOHAMUD · Somalia
$7.91
Top 2 dosage forms
1
Tablet
$8K
2
Capsule
$6K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $1K | $475.06 |
| Nov | 10 | $7K | $687.59 |
| Dec | 16 | $6K | $377.69 |
Shipment register · 29 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BDR PHARMACEUTICALS INTERNATIONAL PVT LTD · 4 shipments · $3K | |||||||||||
| 1 | Nov 2025 | ONLT | Uganda | Tablet | 90 | NOS | $17.58 | $2K | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| 2 | Nov 2025 | ONLT | Uganda | Tablet | 150 | NOS | $10.74 | $2K | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| 3 | Dec 2025 | ONLT | Uganda | Tablet | 90 | NOS | $0.201 | $18.05 | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| 4 | Dec 2025 | ONLT | Uganda | Tablet | 150 | NOS | $0.123 | $18.38 | MUMBAI AIR (SAHAR) | ENTEBBE | SEA |
| SUPPLIER #2 — NEOPHAR PHARMACEUTICALS PVT LTD · 2 shipments · $3K | |||||||||||
| 5 | Dec 2025 | UNLISTED BUYER | Cameroon | Capsule | 1.0K | NOS | $2.62 | $3K | DELHI AIR | DOUALA | AIR |
| 6 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 100 | NOS | $6.08 | $607.63 | DELHI AIR | DOUALA | AIR |
| SUPPLIER #3 — SANSKRUTI PHARMA · 4 shipments · $3K | |||||||||||
| 7 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 25 | NOS | $30.68 | $766.97 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 8 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 25 | NOS | $29.50 | $737.44 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 9 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Tablet | 25 | NOS | $29.50 | $737.44 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 10 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 20 | NOS | $27.59 | $551.84 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #4 — R.S. SURGIPHARM PVT LTD · 1 shipments · $2K | |||||||||||
| 11 | Dec 2025 | UNKNOWN BUYER | Kenya | Capsule | 150 | PCS | $10.96 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #5 — SPR ONCOCARE PVT LTD · 2 shipments · $1K | |||||||||||
| 12 | Oct 2025 | ATLANT ATTIBIA PHARMACEUTICALS | Libya | Tablet | 10 | NOS | $44.59 | $445.88 | BANGALORE AIR | BENGHAZI | AIR |
| 13 | Oct 2025 | ATLANT ATTIBIA PHARMACEUTICALS | Libya | Tablet | 10 | NOS | $97.76 | $977.57 | BANGALORE AIR | BENGHAZI | AIR |
| SUPPLIER #6 — SAYAR LIFE-CARE · 1 shipments · $791.42 | |||||||||||
| 14 | Nov 2025 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | Capsule | 720 | NOS | $1.10 | $791.42 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #7 — RUN MEDWAY · 1 shipments · $611.96 | |||||||||||
| 15 | Dec 2025 | CLYZ PHARMA SARL | Cameroon | Capsule | 50 | NOS | $12.24 | $611.96 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #8 — K. K. PHARMA SOLUTIONS · 1 shipments · $418.90 | |||||||||||
| 16 | Dec 2025 | UNLISTED BUYER | Libya | Capsule | 8 | NOS | $52.36 | $418.90 | MUMBAI AIR (SAHAR) | TRIPOLI | AIR |
| SUPPLIER #9 — RMPL PHARMA LLP · 2 shipments · $84.58 | |||||||||||
| 17 | Nov 2025 | UNLISTED BUYER | Kenya | Capsule | 3 | NOS | $17.89 | $53.67 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 18 | Nov 2025 | UNLISTED BUYER | Kenya | Capsule | 3 | NOS | $10.30 | $30.91 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #10 — MELON GLOBALCARE · 3 shipments · $50.02 | |||||||||||
| 19 | Nov 2025 | UNLISTED BUYER | Cameroon | Tablet | 1 | NOS | $12.60 | $12.60 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 20 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 1 | NOS | $24.94 | $24.94 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 21 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 1 | NOS | $12.47 | $12.47 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #11 — AL-ROYAL PHARMACEUTICAL PVT LTD · 2 shipments · $47.69 | |||||||||||
| 22 | Dec 2025 | ROYAL PHARMA COMPANY | Egypt | Capsule | 150 | NOS | $0.158 | $23.68 | DELHI AIR | ALEXANDRIA, EL NHOUZ | AIR |
| 23 | Dec 2025 | ROYAL PHARMA COMPANY | Egypt | Capsule | 300 | NOS | $0.080 | $24.01 | DELHI AIR | ALEXANDRIA, EL NHOUZ | AIR |
| SUPPLIER #12 — VINAYAK DRUGS AND SURGICALS · 3 shipments · $9.34 | |||||||||||
| 24 | Dec 2025 | UNKNOWN BUYER | Nigeria | Tablet | 200 | NOS | $0.040 | $7.93 | DELHI AIR | KANO | AIR |
| 25 | Dec 2025 | UNKNOWN BUYER | Nigeria | Tablet | 4 | NOS | $0.101 | $0.403 | DELHI AIR | KANO | AIR |
| 26 | Dec 2025 | UNKNOWN BUYER | Nigeria | Tablet | 5 | NOS | $0.202 | $1.01 | DELHI AIR | KANO | AIR |
| SUPPLIER #13 — M T MADON EXPORTS · 2 shipments · $7.91 | |||||||||||
| 27 | Dec 2025 | MOHAMED AHEMED MOHAMUD | Somalia | Capsule | 30 | NOS | $0.079 | $2.36 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 28 | Dec 2025 | MOHAMED AHEMED MOHAMUD | Somalia | Capsule | 30 | NOS | $0.185 | $5.55 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #14 — YOGI CARE PHARMACEUTICAL PVT LTD · 1 shipments · $1.72 | |||||||||||
| 29 | Oct 2025 | UNLISTED BUYER | DR Congo | Tablet | 2 | NOS | $0.862 | $1.72 | AHMEDABAD AIR | LUMBUMBASHI | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
11 countries · 60 shipments · $86K · 25 Indian suppliers · 18 buyers
SHIPMENTS
60
USD
$86K
COUNTRIES
11
SUPPLIERS
25
BUYERS
18
HHI
1,770
moderate
Top 11 destination countries in Asia
1
Afghanistan (39.1%)
$34K
2
United Arab Emirates (33.0%)
$28K
3
Philippines (13.0%)
$11K
4
Laos (3.7%)
$3K
5
Maldives (3.2%)
$3K
6
Iraq (2.3%)
$2K
7
Singapore (1.7%)
$1K
8
Lebanon (1.7%)
$1K
9
Myanmar (1.2%)
$1K
10
Tajikistan (1.0%)
$823.58
11
Azerbaijan (0.0%)
$8.33
Top 25 Indian suppliers into Asia
1
GENERAL DRUG PVT LTD
$28K
2
SALUS PHARMACEUTICALS
$18K
3
RESCUERS LIFE SCIENCES LTD
$8K
4
MALLESHWAR SPECIALITIES
$7K
5
KWALITY PHARMACEUTICALS LTD
$7K
6
PHARMA CHOICE LLP
$4K
7
KASO PHARMACEUTICALS
$2K
8
LEOWIN HEALTHCARE LLP
$2K
9
NU HOSPITALS PVT LTD
$2K
10
VATS INDUSTRIES PVT LTD
$2K
11
RMPL PHARMA LLP
$1K
12
AVIXX PHARMA LLP
$1K
13
GALAXY SUPER SPECIALITY
$823.58
14
SEATRACK INTERNATIONAL TRADEX PVT LTD
$605.61
15
HEMS ( INDIA )
$532.68
16
MC PHARMA DISTRIBUTORS
$406.21
17
ASPIDA LIFE SCIENCES PVT LTD
$383.09
18
KERK
$273.20
19
AKSHAR PHARMA
$264.06
20
SARTAJ PHARMA PVT LTD
$261.15
21
HEET HEALTHCARE PVT LTD
$191.93
22
PHARMASTAR TRADES INTERNATIONAL
$19.50
23
ONCOHEAL HEALTHCARE LLP
$6.99
24
RELICURE HEALTHCARE
$2.44
25
EXQUISITE PHARMA LLP
$0.0000
Top 16 Asia importers
1
BEHZAD EMRAN LTD · Afghanistan
$18K
2
ETEMED MOSLEH LTD · Afghanistan
$8K
3
RENATO C LOZADA · Philippines
$7K
4
TRUST ANESTHETIC LTD · Afghanistan
$7K
5
IMPORT INNOVATORS VENTURES INC · Philippines
$4K
6
NANG DAO · Laos
$2K
7
INDIRA GANDHI MEMOROAL HOSPITAL · Maldives
$2K
8
ATLAS TRADING COMPANY · Iraq
$2K
9
SHINE KHANT CO LTD · Myanmar
$1K
10
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$605.61
11
STATE TRADING ORGANIZATION PLC · Maldives
$406.21
12
LINDEE ENTERPRISES PTE LTD · Singapore
$273.20
13
SARTAJ ENTERPRISES LTD · Afghanistan
$261.15
14
NAME : AYGUN · Azerbaijan
$8.33
15
ZHARAWA LTD · Iraq
$2.44
16
KHAMPARN VANGXAIHOUA · Laos
$0.0000
Top 3 dosage forms
1
Capsule
$52K
2
Tablet
$34K
3
Unknown
$30.61
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 9 | $8K | $905.93 |
| Nov | 10 | $56K | $6K |
| Dec | 41 | $22K | $532.18 |
Shipment register · 60 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — GENERAL DRUG PVT LTD · 1 shipments · $28K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 42 | PCS | $660.83 | $28K | AHMEDABAD AIR | DUBAI | AIR |
| SUPPLIER #2 — SALUS PHARMACEUTICALS · 1 shipments · $18K | |||||||||||
| 2 | Nov 2025 | BEHZAD EMRAN LTD | Afghanistan | Capsule | 10.0K | NOS | $1.82 | $18K | DELHI AIR | KABUL | AIR |
| SUPPLIER #3 — RESCUERS LIFE SCIENCES LTD · 5 shipments · $8K | |||||||||||
| 3 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Capsule | 700 | NOS | $2.09 | $1K | DELHI AIR | KABUL | AIR |
| 4 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Capsule | 490 | NOS | $4.42 | $2K | DELHI AIR | KABUL | AIR |
| 5 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Capsule | 300 | NOS | $2.10 | $630.67 | DELHI AIR | KABUL | AIR |
| 6 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Capsule | 700 | NOS | $2.09 | $1K | DELHI AIR | KABUL | AIR |
| 7 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Capsule | 490 | NOS | $4.42 | $2K | DELHI AIR | KABUL | AIR |
| SUPPLIER #4 — MALLESHWAR SPECIALITIES · 6 shipments · $7K | |||||||||||
| 8 | Oct 2025 | RENATO C LOZADA | Philippines | Capsule | 10 | NOS | $49.20 | $492.03 | BANGALORE AIR | MANILA | AIR |
| 9 | Oct 2025 | RENATO C LOZADA | Philippines | Capsule | 40 | NOS | $49.20 | $2K | BANGALORE AIR | MANILA | AIR |
| 10 | Oct 2025 | RENATO C LOZADA | Philippines | Capsule | 10 | NOS | $49.20 | $492.03 | BANGALORE AIR | MANILA | AIR |
| 11 | Oct 2025 | RENATO C LOZADA | Philippines | Capsule | 40 | NOS | $49.20 | $2K | BANGALORE AIR | MANILA | AIR |
| 12 | Oct 2025 | RENATO C LOZADA | Philippines | Capsule | 10 | NOS | $49.20 | $492.03 | BANGALORE AIR | MANILA | AIR |
| 13 | Oct 2025 | RENATO C LOZADA | Philippines | Capsule | 40 | NOS | $49.20 | $2K | BANGALORE AIR | MANILA | AIR |
| SUPPLIER #5 — KWALITY PHARMACEUTICALS LTD · 1 shipments · $7K | |||||||||||
| 14 | Nov 2025 | TRUST ANESTHETIC LTD | Afghanistan | Capsule | 15.0K | NOS | $0.480 | $7K | DELHI AIR | KABUL | AIR |
| SUPPLIER #6 — PHARMA CHOICE LLP · 2 shipments · $4K | |||||||||||
| 15 | Dec 2025 | IMPORT INNOVATORS VENTURES INC | Philippines | Tablet | 200 | NOS | $13.87 | $3K | MUMBAI AIR (SAHAR) | CLARK INTER. AIRPORT | AIR |
| 16 | Dec 2025 | IMPORT INNOVATORS VENTURES INC | Philippines | Tablet | 100 | NOS | $10.25 | $1K | MUMBAI AIR (SAHAR) | CLARK INTER. AIRPORT | AIR |
| SUPPLIER #7 — KASO PHARMACEUTICALS · 2 shipments · $2K | |||||||||||
| 17 | Dec 2025 | NANG DAO | Laos | Tablet | 20 | NOS | $44.58 | $891.60 | DELHI AIR | VIENTIANE | AIR |
| 18 | Dec 2025 | NANG DAO | Laos | Tablet | 50 | NOS | $23.08 | $1K | DELHI AIR | VIENTIANE | AIR |
| SUPPLIER #8 — LEOWIN HEALTHCARE LLP · 3 shipments · $2K | |||||||||||
| 19 | Dec 2025 | UNLISTED BUYER | Singapore | Capsule | 45 | NOS | $15.31 | $688.84 | AHMEDABAD AIR | SINGAPORE | AIR |
| 20 | Dec 2025 | UNLISTED BUYER | Singapore | Capsule | 30 | NOS | $15.31 | $459.23 | AHMEDABAD AIR | SINGAPORE | AIR |
| 21 | Dec 2025 | UNLISTED BUYER | Laos | Capsule | 30 | NOS | $24.48 | $734.35 | AHMEDABAD AIR | VIENTIANE | AIR |
| SUPPLIER #9 — NU HOSPITALS PVT LTD · 2 shipments · $2K | |||||||||||
| 22 | Nov 2025 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | Capsule | 270 | NOS | $3.40 | $917.44 | BANGALORE AIR | MALE | AIR |
| 23 | Nov 2025 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | Capsule | 270 | NOS | $3.40 | $917.44 | BANGALORE AIR | MALE | AIR |
| SUPPLIER #10 — VATS INDUSTRIES PVT LTD · 1 shipments · $2K | |||||||||||
| 24 | Dec 2025 | ATLAS TRADING COMPANY | Iraq | Capsule | 50 | NOS | $31.04 | $2K | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #11 — RMPL PHARMA LLP · 2 shipments · $1K | |||||||||||
| 25 | Nov 2025 | UNLISTED BUYER | Lebanon | Capsule | 50 | NOS | $7.92 | $395.88 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 26 | Dec 2025 | UNLISTED BUYER | Lebanon | Capsule | 25 | NOS | $41.84 | $1K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #12 — AVIXX PHARMA LLP · 1 shipments · $1K | |||||||||||
| 27 | Dec 2025 | SHINE KHANT CO LTD | Myanmar | Capsule | 250 | NOS | $4.18 | $1K | DELHI AIR | YANGON | AIR |
| SUPPLIER #13 — GALAXY SUPER SPECIALITY · 1 shipments · $823.58 | |||||||||||
| 28 | Dec 2025 | UNLISTED BUYER | Tajikistan | Capsule | 20 | NOS | $41.18 | $823.58 | DELHI AIR | TASHKENT | AIR |
| SUPPLIER #14 — SEATRACK INTERNATIONAL TRADEX PVT LTD · 1 shipments · $605.61 | |||||||||||
| 29 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Capsule | 20 | NOS | $30.28 | $605.61 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #15 — HEMS ( INDIA ) · 1 shipments · $532.68 | |||||||||||
| 30 | Oct 2025 | UNLISTED BUYER | Maldives | Capsule | 450 | NOS | $1.18 | $532.68 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #16 — MC PHARMA DISTRIBUTORS · 5 shipments · $406.21 | |||||||||||
| 31 | Oct 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Capsule | 130 | NOS | $0.911 | $118.49 | CHENNAI AIR | MALE | AIR |
| 32 | Oct 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Capsule | 150 | PCS | $0.812 | $121.79 | CHENNAI AIR | MALE | AIR |
| 33 | Nov 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Capsule | 90 | PCS | $0.820 | $73.83 | CHENNAI AIR | MALE | AIR |
| 34 | Nov 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Capsule | 90 | PCS | $0.751 | $67.60 | CHENNAI AIR | MALE | AIR |
| 35 | Nov 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Capsule | 30 | PCS | $0.817 | $24.50 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #17 — ASPIDA LIFE SCIENCES PVT LTD · 4 shipments · $383.09 | |||||||||||
| 36 | Dec 2025 | KHAMPARN VANGXAIHOUA | Laos | Capsule | 30 | NOS | $0.0000 | $0.0000 | DELHI AIR | VIENTIANE | AIR |
| 37 | Dec 2025 | KHAMPARN VANGXAIHOUA | Laos | Capsule | 50 | NOS | $0.0000 | $0.0000 | DELHI AIR | VIENTIANE | AIR |
| 38 | Dec 2025 | UNLISTED BUYER | Laos | Capsule | 30 | NOS | $3.41 | $102.29 | DELHI AIR | VIENTIANE | AIR |
| 39 | Dec 2025 | UNLISTED BUYER | Laos | Capsule | 50 | NOS | $5.62 | $280.80 | DELHI AIR | VIENTIANE | AIR |
| SUPPLIER #18 — KERK · 1 shipments · $273.20 | |||||||||||
| 40 | Nov 2025 | LINDEE ENTERPRISES PTE LTD | Singapore | Capsule | 30 | NOS | $9.11 | $273.20 | DELHI AIR | SINGAPORE | AIR |
| SUPPLIER #19 — AKSHAR PHARMA · 1 shipments · $264.06 | |||||||||||
| 41 | Dec 2025 | UNLISTED BUYER | Iraq | Tablet | 10 | PCS | $26.41 | $264.06 | MUMBAI AIR (SAHAR) | BASRA | AIR |
| SUPPLIER #20 — SARTAJ PHARMA PVT LTD · 2 shipments · $261.15 | |||||||||||
| 42 | Dec 2025 | SARTAJ ENTERPRISES LTD | Afghanistan | Capsule | 1.6K | NOS | $0.098 | $159.56 | TUGHLAKABAD ICD | Kandahar | ICD |
| 43 | Dec 2025 | SARTAJ ENTERPRISES LTD | Afghanistan | Capsule | 2.2K | NOS | $0.046 | $101.59 | TUGHLAKABAD ICD | Kandahar | AIR |
| SUPPLIER #21 — HEET HEALTHCARE PVT LTD · 6 shipments · $191.93 | |||||||||||
| 44 | Dec 2025 | UNLISTED BUYER | Singapore | 5 | NOS | $6.12 | $30.61 | AHMEDABAD AIR | SINGAPORE | AIR | |
| 45 | Dec 2025 | NAME : AYGUN | Azerbaijan | Tablet | 10 | NOS | $0.349 | $3.49 | MUMBAI AIR (SAHAR) | BAKU | AIR |
| 46 | Dec 2025 | NAME : AYGUN | Azerbaijan | Tablet | 10 | NOS | $0.108 | $1.08 | MUMBAI AIR (SAHAR) | BAKU | AIR |
| 47 | Dec 2025 | NAME : AYGUN | Azerbaijan | Tablet | 10 | NOS | $0.114 | $1.14 | MUMBAI AIR (SAHAR) | BAKU | AIR |
| 48 | Dec 2025 | NAME : AYGUN | Azerbaijan | Tablet | 20 | NOS | $0.131 | $2.62 | MUMBAI AIR (SAHAR) | BAKU | AIR |
| 49 | Dec 2025 | UNLISTED BUYER | Iraq | Capsule | 5 | NOS | $30.60 | $152.99 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #22 — PHARMASTAR TRADES INTERNATIONAL · 3 shipments · $19.50 | |||||||||||
| 50 | Dec 2025 | UNLISTED BUYER | Singapore | Capsule | 10 | NOS | $0.237 | $2.37 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 51 | Dec 2025 | UNLISTED BUYER | Singapore | Capsule | 30 | NOS | $0.553 | $16.58 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 52 | Dec 2025 | UNLISTED BUYER | Singapore | Capsule | 1 | NOS | $0.553 | $0.553 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #23 — ONCOHEAL HEALTHCARE LLP · 3 shipments · $6.99 | |||||||||||
| 53 | Dec 2025 | UNKNOWN BUYER | Laos | Tablet | 30 | NOS | $0.085 | $2.56 | MUMBAI AIR (SAHAR) | VIENTIANE | AIR |
| 54 | Dec 2025 | UNLISTED BUYER | Laos | Tablet | 19 | NOS | $0.042 | $0.805 | MUMBAI AIR (SAHAR) | VIENTIANE | AIR |
| 55 | Dec 2025 | UNLISTED BUYER | Laos | Tablet | 50 | NOS | $0.072 | $3.62 | MUMBAI AIR (SAHAR) | VIENTIANE | AIR |
| SUPPLIER #24 — RELICURE HEALTHCARE · 1 shipments · $2.44 | |||||||||||
| 56 | Dec 2025 | ZHARAWA LTD | Iraq | Capsule | 5 | NOS | $0.488 | $2.44 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #25 — EXQUISITE PHARMA LLP · 4 shipments · $0.0000 | |||||||||||
| 57 | Dec 2025 | UNLISTED BUYER | Philippines | Capsule | 15 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 58 | Dec 2025 | UNLISTED BUYER | Philippines | Capsule | 15 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 59 | Dec 2025 | UNLISTED BUYER | Philippines | Capsule | 15 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 60 | Dec 2025 | UNLISTED BUYER | Philippines | Capsule | 15 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | MANILA | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
2 countries · 4 shipments · $2K · 2 Indian suppliers · 2 buyers
SHIPMENTS
4
USD
$2K
COUNTRIES
2
SUPPLIERS
2
BUYERS
2
HHI
6,404
concentrated
Top 2 destination countries in Europe
1
Switzerland (76.5%)
$1K
2
Poland (23.5%)
$386.34
Top 2 Indian suppliers into Europe
1
JPC GLOBAL
$1K
2
HEET HEALTHCARE PVT LTD
$386.34
Top 1 Europe importers
1
TO THE, IMPORTING DEPARTMENT · Switzerland
$1K
Top 2 dosage forms
1
Tablet
$1K
2
Unknown
$386.34
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 3 | $386.34 | $128.78 |
| Dec | 1 | $1K | $1K |
Shipment register · 4 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — JPC GLOBAL · 1 shipments · $1K | |||||||||||
| 1 | Dec 2025 | TO THE, IMPORTING DEPARTMENT | Switzerland | Tablet | 60 | PCS | $20.96 | $1K | MUMBAI AIR (SAHAR) | ZURICH | AIR |
| SUPPLIER #2 — HEET HEALTHCARE PVT LTD · 3 shipments · $386.34 | |||||||||||
| 2 | Nov 2025 | UNLISTED BUYER | Poland | 3 | NOS | $42.93 | $128.78 | AHMEDABAD AIR | WARSAW | AIR | |
| 3 | Nov 2025 | UNLISTED BUYER | Poland | 3 | NOS | $42.93 | $128.78 | AHMEDABAD AIR | WARSAW | AIR | |
| 4 | Nov 2025 | UNLISTED BUYER | Poland | 3 | NOS | $42.93 | $128.78 | AHMEDABAD AIR | WARSAW | AIR | |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
6 countries · 23 shipments · $11K · 11 Indian suppliers · 8 buyers
SHIPMENTS
23
USD
$11K
COUNTRIES
6
SUPPLIERS
11
BUYERS
8
HHI
2,361
moderate
Top 6 destination countries in Americas
1
Mexico (50.4%)
$5K
2
Jamaica (15.5%)
$2K
3
Brazil (11.5%)
$1K
4
Venezuela (10.3%)
$1K
5
Chile (6.8%)
$725.78
6
British Virgin Islands (5.5%)
$590.80
Top 11 Indian suppliers into Americas
1
MYGENIC HEALTHCARE PVT LTD
$5K
2
SHREE KRISHNA LIFECARE
$2K
3
GALAXY SUPER SPECIALITY
$1K
4
SPECIALITY MEDICINES LTD
$1K
5
VAMA HEALTH WORLD LLP
$727.11
6
KALINDI OVERSEAS
$672.19
7
SARA TRADING CORP
$590.80
8
SANSKRUTI PHARMA
$143.79
9
MEDINEX HEALTHCARE
$132.39
10
NIVIRA EXPORTS
$53.60
11
JEEDNYA PHARMA
$2.70
Top 6 Americas importers
1
DRJOHN NEWMAN · Jamaica
$2K
2
AS PER INVOICE MEXICO · Mexico
$727.11
3
VANTERPOOL ENTERPRISES LTD · British Virgin Islands
$590.80
4
THE PURCHASE DEPARTMENT LLC · Chile
$336.09
5
FARMACIA ETICA SPA · Chile
$53.60
6
TISHEENA ROACH (BSO) · Jamaica
$2.70
Top 2 dosage forms
1
Capsule
$10K
2
Tablet
$587.46
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 5 | $2K | $354.29 |
| Dec | 18 | $9K | $493.82 |
Shipment register · 23 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MYGENIC HEALTHCARE PVT LTD · 6 shipments · $5K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Mexico | Capsule | 20 | NOS | $38.80 | $775.92 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 2 | Dec 2025 | UNLISTED BUYER | Mexico | Capsule | 40 | NOS | $18.23 | $729.37 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 3 | Dec 2025 | UNLISTED BUYER | Mexico | Capsule | 20 | NOS | $38.80 | $775.92 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 4 | Dec 2025 | UNLISTED BUYER | Mexico | Capsule | 40 | NOS | $18.23 | $729.37 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 5 | Dec 2025 | UNLISTED BUYER | Mexico | Capsule | 20 | NOS | $38.76 | $775.15 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 6 | Dec 2025 | UNLISTED BUYER | Mexico | Capsule | 40 | NOS | $18.22 | $728.63 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #2 — SHREE KRISHNA LIFECARE · 2 shipments · $2K | |||||||||||
| 7 | Dec 2025 | DRJOHN NEWMAN | Jamaica | Capsule | 3 | NOS | $136.67 | $410.02 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 8 | Dec 2025 | DRJOHN NEWMAN | Jamaica | Capsule | 6 | NOS | $206.02 | $1K | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| SUPPLIER #3 — GALAXY SUPER SPECIALITY · 2 shipments · $1K | |||||||||||
| 9 | Nov 2025 | UNLISTED BUYER | Venezuela | Capsule | 10 | NOS | $19.93 | $199.35 | DELHI AIR | MADRID | AIR |
| 10 | Nov 2025 | UNLISTED BUYER | Venezuela | Capsule | 20 | NOS | $44.86 | $897.20 | DELHI AIR | MADRID | AIR |
| SUPPLIER #4 — SPECIALITY MEDICINES LTD · 2 shipments · $1K | |||||||||||
| 11 | Dec 2025 | UNLISTED BUYER | Brazil | Capsule | 4 | SET | $170.71 | $682.83 | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
| 12 | Dec 2025 | UNLISTED BUYER | Brazil | Capsule | 6 | SET | $66.29 | $397.73 | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
| SUPPLIER #5 — VAMA HEALTH WORLD LLP · 1 shipments · $727.11 | |||||||||||
| 13 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Capsule | 15 | NOS | $48.47 | $727.11 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #6 — KALINDI OVERSEAS · 2 shipments · $672.19 | |||||||||||
| 14 | Nov 2025 | THE PURCHASE DEPARTMENT LLC | Chile | Capsule | 12 | NOS | $28.01 | $336.09 | MUMBAI AIR (SAHAR) | SANTIAGO DE CHILE - | AIR |
| 15 | Nov 2025 | UNKNOWN BUYER | Chile | Capsule | 12 | NOS | $28.01 | $336.09 | MUMBAI AIR (SAHAR) | SANTIAGO DE CHILE - | AIR |
| SUPPLIER #7 — SARA TRADING CORP · 2 shipments · $590.80 | |||||||||||
| 16 | Dec 2025 | VANTERPOOL ENTERPRISES LTD | British Virgin Islands | Capsule | 4 | NOS | $69.88 | $279.52 | MUMBAI AIR (SAHAR) | TORTOLA | AIR |
| 17 | Dec 2025 | VANTERPOOL ENTERPRISES LTD | British Virgin Islands | Tablet | 6 | NOS | $51.88 | $311.28 | MUMBAI AIR (SAHAR) | TORTOLA | AIR |
| SUPPLIER #8 — SANSKRUTI PHARMA · 2 shipments · $143.79 | |||||||||||
| 18 | Dec 2025 | UNLISTED BUYER | Brazil | Tablet | 18 | NOS | $1.42 | $25.50 | MUMBAI AIR (SAHAR) | Viracopos | AIR |
| 19 | Dec 2025 | UNLISTED BUYER | Brazil | Tablet | 36 | NOS | $3.29 | $118.29 | MUMBAI AIR (SAHAR) | Viracopos | AIR |
| SUPPLIER #9 — MEDINEX HEALTHCARE · 1 shipments · $132.39 | |||||||||||
| 20 | Dec 2025 | UNLISTED BUYER | Mexico | Tablet | 5 | NOS | $26.48 | $132.39 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #10 — NIVIRA EXPORTS · 2 shipments · $53.60 | |||||||||||
| 21 | Dec 2025 | FARMACIA ETICA SPA | Chile | Capsule | 1 | NOS | $31.80 | $31.80 | MUMBAI AIR (SAHAR) | SANTIAGO DE CHILE - | AIR |
| 22 | Dec 2025 | FARMACIA ETICA SPA | Chile | Capsule | 1 | NOS | $21.80 | $21.80 | MUMBAI AIR (SAHAR) | SANTIAGO DE CHILE - | AIR |
| SUPPLIER #11 — JEEDNYA PHARMA · 1 shipments · $2.70 | |||||||||||
| 23 | Nov 2025 | TISHEENA ROACH (BSO) | Jamaica | Capsule | 90 | NOS | $0.030 | $2.70 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 48 Indian lenvatinib exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped lenvatinib in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | GENERAL DRUG PVT LTD | MUMBAI | 1 | $28K | Tablet | Asia |
| 2 | SALUS PHARMACEUTICALS | BADDI | 1 | $18K | Capsule | Asia |
| 3 | RESCUERS LIFE SCIENCES LTD | NALAGARH ROAD BADDI | 5 | $8K | Capsule | Asia |
| 4 | MALLESHWAR SPECIALITIES | BANGALORE | 6 | $7K | Capsule | Asia |
| 5 | KWALITY PHARMACEUTICALS LTD | AMRITSAR | 1 | $7K | Capsule | Asia |
| 6 | MYGENIC HEALTHCARE PVT LTD | NAVI MUMBAI | 6 | $5K | Capsule | Americas |
| 7 | PHARMA CHOICE LLP | MULUND EAST | 2 | $4K | Tablet | Asia |
| 8 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | MUMBAI | 4 | $3K | Tablet | Africa |
| 9 | NEOPHAR PHARMACEUTICALS PVT LTD | DELHI | 2 | $3K | Capsule, Tablet | Africa |
| 10 | SANSKRUTI PHARMA | SURAT | 6 | $3K | Tablet | Africa, Americas |
| 11 | KASO PHARMACEUTICALS | NEW DELHI | 2 | $2K | Tablet | Asia |
| 12 | GALAXY SUPER SPECIALITY | NEW DELHI | 3 | $2K | Capsule | Americas, Asia |
| 13 | LEOWIN HEALTHCARE LLP | GANDHINAGAR | 3 | $2K | Capsule | Asia |
| 14 | NU HOSPITALS PVT LTD | BENGALURU | 2 | $2K | Capsule | Asia |
| 15 | SHREE KRISHNA LIFECARE | MULUND WEST | 2 | $2K | Capsule | Americas |
| 16 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 1 | $2K | Capsule | Africa |
| 17 | VATS INDUSTRIES PVT LTD | NEW DELHI | 1 | $2K | Capsule | Asia |
| 18 | RMPL PHARMA LLP | MUMBAI | 4 | $2K | Capsule | Asia, Africa |
| 19 | SPR ONCOCARE PVT LTD | BANGALORE | 2 | $1K | Tablet | Africa |
| 20 | JPC GLOBAL | MUMBAI | 1 | $1K | Tablet | Europe |
| 21 | SPECIALITY MEDICINES LTD | MUMBAI | 2 | $1K | Capsule | Americas |
| 22 | AVIXX PHARMA LLP | DELHI | 1 | $1K | Capsule | Asia |
| 23 | SAYAR LIFE-CARE | Chennai | 1 | $791.42 | Capsule | Africa |
| 24 | VAMA HEALTH WORLD LLP | Mumbai | 1 | $727.11 | Capsule | Americas |
| 25 | KALINDI OVERSEAS | MUMBAI | 2 | $672.19 | Capsule | Americas |
| 26 | RUN MEDWAY | SURAT | 1 | $611.96 | Capsule | Africa |
| 27 | SEATRACK INTERNATIONAL TRADEX PVT LTD | NEW DELHI | 1 | $605.61 | Capsule | Asia |
| 28 | SARA TRADING CORP | JABALPUR | 2 | $590.80 | Capsule, Tablet | Americas |
| 29 | HEET HEALTHCARE PVT LTD | AHMEDABAD | 9 | $578.27 | Tablet, Capsule | Europe, Asia |
| 30 | HEMS ( INDIA ) | CHENNAI | 1 | $532.68 | Capsule | Asia |
| 31 | K. K. PHARMA SOLUTIONS | BANDRA EAST | 1 | $418.90 | Capsule | Africa |
| 32 | MC PHARMA DISTRIBUTORS | CHENNAI | 5 | $406.21 | Capsule | Asia |
| 33 | ASPIDA LIFE SCIENCES PVT LTD | GHAZIABAD | 4 | $383.09 | Capsule | Asia |
| 34 | KERK | DELHI | 1 | $273.20 | Capsule | Asia |
| 35 | AKSHAR PHARMA | SURAT | 1 | $264.06 | Tablet | Asia |
| 36 | SARTAJ PHARMA PVT LTD | CHANDNI CHOWK | 2 | $261.15 | Capsule | Asia |
| 37 | MEDINEX HEALTHCARE | Mumbai | 1 | $132.39 | Tablet | Americas |
| 38 | NIVIRA EXPORTS | MUMBAI | 2 | $53.60 | Capsule | Americas |
| 39 | MELON GLOBALCARE | MUMBAI | 3 | $50.02 | Tablet | Africa |
| 40 | AL-ROYAL PHARMACEUTICAL PVT LTD | NEW DELHI | 2 | $47.69 | Capsule | Africa |
| 41 | PHARMASTAR TRADES INTERNATIONAL | PUNE | 3 | $19.50 | Capsule | Asia |
| 42 | VINAYAK DRUGS AND SURGICALS | New Delhi | 3 | $9.34 | Tablet | Africa |
| 43 | M T MADON EXPORTS | MUMBAI | 2 | $7.91 | Capsule | Africa |
| 44 | ONCOHEAL HEALTHCARE LLP | Ahmedabad | 3 | $6.99 | Tablet | Asia |
| 45 | JEEDNYA PHARMA | VASHI NAVI MUMBAI | 1 | $2.70 | Capsule | Americas |
| 46 | RELICURE HEALTHCARE | DELHI | 1 | $2.44 | Capsule | Asia |
| 47 | YOGI CARE PHARMACEUTICAL PVT LTD | AHMEDABAD | 1 | $1.72 | Tablet | Africa |
| 48 | EXQUISITE PHARMA LLP | Mumbai | 4 | $0.0000 | Capsule | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 29 global lenvatinib importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian lenvatinib in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | BEHZAD EMRAN LTD | Afghanistan | 1 | $18K | SALUS PHARMACEUTICALS | Capsule |
| 2 | ETEMED MOSLEH LTD | Afghanistan | 5 | $8K | RESCUERS LIFE SCIENC… | Capsule |
| 3 | RENATO C LOZADA | Philippines | 6 | $7K | MALLESHWAR SPECIALIT… | Capsule |
| 4 | TRUST ANESTHETIC LTD | Afghanistan | 1 | $7K | KWALITY PHARMACEUTIC… | Capsule |
| 5 | IMPORT INNOVATORS VENTURES INC | Philippines | 2 | $4K | PHARMA CHOICE LLP | Tablet |
| 6 | ONLT | Uganda | 4 | $3K | BDR PHARMACEUTICALS … | Tablet |
| 7 | NANG DAO | Laos | 2 | $2K | KASO PHARMACEUTICALS | Tablet |
| 8 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | 2 | $2K | NU HOSPITALS PVT LTD | Capsule |
| 9 | DRJOHN NEWMAN | Jamaica | 2 | $2K | SHREE KRISHNA LIFECARE | Capsule |
| 10 | ATLAS TRADING COMPANY | Iraq | 1 | $2K | VATS INDUSTRIES PVT … | Capsule |
| 11 | ATLANT ATTIBIA PHARMACEUTICALS | Libya | 2 | $1K | SPR ONCOCARE PVT LTD | Tablet |
| 12 | TO THE, IMPORTING DEPARTMENT | Switzerland | 1 | $1K | JPC GLOBAL | Tablet |
| 13 | SHINE KHANT CO LTD | Myanmar | 1 | $1K | AVIXX PHARMA LLP | Capsule |
| 14 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | 1 | $791.42 | SAYAR LIFE-CARE | Capsule |
| 15 | AS PER INVOICE MEXICO | Mexico | 1 | $727.11 | VAMA HEALTH WORLD LLP | Capsule |
| 16 | CLYZ PHARMA SARL | Cameroon | 1 | $611.96 | RUN MEDWAY | Capsule |
| 17 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 1 | $605.61 | SEATRACK INTERNATION… | Capsule |
| 18 | VANTERPOOL ENTERPRISES LTD | British Virgin Islands | 2 | $590.80 | SARA TRADING CORP | Capsule, Tablet |
| 19 | STATE TRADING ORGANIZATION PLC | Maldives | 5 | $406.21 | MC PHARMA DISTRIBUTORS | Capsule |
| 20 | THE PURCHASE DEPARTMENT LLC | Chile | 1 | $336.09 | KALINDI OVERSEAS | Capsule |
| 21 | LINDEE ENTERPRISES PTE LTD | Singapore | 1 | $273.20 | KERK | Capsule |
| 22 | SARTAJ ENTERPRISES LTD | Afghanistan | 2 | $261.15 | SARTAJ PHARMA PVT LTD | Capsule |
| 23 | FARMACIA ETICA SPA | Chile | 2 | $53.60 | NIVIRA EXPORTS | Capsule |
| 24 | ROYAL PHARMA COMPANY | Egypt | 2 | $47.69 | AL-ROYAL PHARMACEUTI… | Capsule |
| 25 | NAME : AYGUN | Azerbaijan | 4 | $8.33 | HEET HEALTHCARE PVT … | Tablet |
| 26 | MOHAMED AHEMED MOHAMUD | Somalia | 2 | $7.91 | M T MADON EXPORTS | Capsule |
| 27 | TISHEENA ROACH (BSO) | Jamaica | 1 | $2.70 | JEEDNYA PHARMA | Capsule |
| 28 | ZHARAWA LTD | Iraq | 1 | $2.44 | RELICURE HEALTHCARE | Capsule |
| 29 | KHAMPARN VANGXAIHOUA | Laos | 2 | $0.0000 | ASPIDA LIFE SCIENCES… | Capsule |
This report covers 116 2025-Q4 Lenvatinib shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/lenvatinib
Talk to our trade analyst
Need a custom lenvatinib report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/lenvatinib
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Lenvatinib product page
Live data, supplier directory, price trends, and trade route analysis